Rx only · Injection · Subcutaneous

Ustekinumab-Srlf

Brands: Imuldosa · Ustekinumab-Srlf

1 ACTIVE SUPPLIER — US

openFDA · updated weekly

US2 NDCs
1 active makers

UKComing
soon

CAComing
soon

AUComing
soon

EUComing
soon

ATCL04AC05

RxCUI (US)847083

US makers1 labelers

Packages2

DEA / ScheduleNone

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

Only one quarter on record so far — the trend line fills in as more quarters load.

Rx · 2026 Q1

Units dispensed

Quarters · since 2026 Q1

Who makes it1 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

Labeler	Type	Packages	Status
Accord BioPharma Inc.	unknown	2	SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

Jun 10, 2026
RECALLRecall (Class II): IMULDOSA, (ustekinumab-srlf) Injection, 130 mg/26 mL (5mg/mL), Rx only, Single dose vial, Manufactured by Accord BioPha…
Lack of assurance of Sterility: — Recalling firm: ACCORD BIOPHARMA INC — US Nationwide.